<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ioakeim-Skoufa I</submitter><funding>Carlos III Institute of Health</funding><pagination>2615</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12028097</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(8)</volume><pubmed_abstract>&lt;b>Background:&lt;/b> Managing multimorbidity is a major challenge for healthcare systems. Cardiometabolic multimorbidity (CMM) is highly prevalent and linked to increased disease burden, functional decline, and mortality. While most studies focus on cross-sectional analyses, longitudinal approaches are essential for understanding disease progression and identifying patient groups who may benefit from targeted interventions. &lt;b>Objectives:&lt;/b> This systematic review synthesises evidence from longitudinal studies on the incidence and progression of CMM, exploring transitions between multimorbidity clusters and their clinical implications. &lt;b>Methods:&lt;/b> A systematic search was conducted in MEDLINE and EMBASE following PRISMA guidelines. Studies were included if they employed longitudinal desi</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Charting the Pathways of Cardiometabolic Multimorbidity: A Systematic Review of Clinical Trajectories.</pubmed_title><pmcid>PMC12028097</pmcid><funding_grant_id>RD21/0016/0019</funding_grant_id><pubmed_authors>Hernandez-Rodriguez MA</pubmed_authors><pubmed_authors>Aza-Pascual-Salcedo M</pubmed_authors><pubmed_authors>Avedillo-Salas A</pubmed_authors><pubmed_authors>Gimeno-Miguel A</pubmed_authors><pubmed_authors>Ledesma-Calvo R</pubmed_authors><pubmed_authors>Ioakeim-Skoufa I</pubmed_authors><pubmed_authors>Moreno-Juste A</pubmed_authors><pubmed_authors>Cebollada-Herrera C</pubmed_authors><pubmed_authors>Atkins K</pubmed_authors><pubmed_authors>Lasala-Aza C</pubmed_authors><pubmed_authors>Gonzalez-Rubio F</pubmed_authors><pubmed_authors>Esteban-Jimenez O</pubmed_authors><pubmed_authors>Vicente-Romero J</pubmed_authors><pubmed_authors>Roque F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Charting the Pathways of Cardiometabolic Multimorbidity: A Systematic Review of Clinical Trajectories.</name><description>&lt;b>Background:&lt;/b> Managing multimorbidity is a major challenge for healthcare systems. Cardiometabolic multimorbidity (CMM) is highly prevalent and linked to increased disease burden, functional decline, and mortality. While most studies focus on cross-sectional analyses, longitudinal approaches are essential for understanding disease progression and identifying patient groups who may benefit from targeted interventions. &lt;b>Objectives:&lt;/b> This systematic review synthesises evidence from longitudinal studies on the incidence and progression of CMM, exploring transitions between multimorbidity clusters and their clinical implications. &lt;b>Methods:&lt;/b> A systematic search was conducted in MEDLINE and EMBASE following PRISMA guidelines. Studies were included if they employed longitudinal desi</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-03T03:04:45.535Z</modification><creation>2025-07-03T03:04:45.535Z</creation></dates><accession>S-EPMC12028097</accession><cross_references><pubmed>40283445</pubmed><doi>10.3390/jcm14082615</doi></cross_references></HashMap>